Zimmer Biomet Operating Cash Flow — Historical Data
Zimmer Biomet (ZBH) operating cash flow was $1.7B in FY2025 (+13% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$1.7B
+13%
2024
$1.5B
-5%
2023
$1.6B
+17%
2022
$1.4B
-3%
2021
$1.4B
+31%
2020
$1.1B
-32%
2019
$1.6B
-9%
2018
$1.7B
+10%
2017
$1.6B
-3%
2016
$1.6B
+92%
2015
$850M
-20%
2014
$1.1B
+10%
2013
$963M
-16%
2012
$1.2B
-2%
2011
$1.2B
-1%
2010
$1.2B
+7%
2009
$1.1B
+8%
2008
$1.0B
-4%
2007
$1.1B
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q2 2026
$448M
Q1 2026
$359M
Q4 2025
$517M
Q3 2025
$419M
Q2 2025
$378M
Q1 2025
$383M
Q4 2024
$506M
Q3 2024
$396M
Q2 2024
$369M
Q1 2024
$228M
Q4 2023
$588M
Q3 2023
$338M
Source: ZBH on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.